OssDsign, a portfolio company of Karolinska Development, has applied for listing on Nasdaq First North. OssDsign will issue a share capital worth SEK 151.3m. The pre-money valuation of the firm is SEK 336. OssDsign develops implants for improved healing and treatment of bone defects. OssDsign reported a turnover of SEK 13.3m and EBITDA of SEK -47.8m in 2018, which corresponds to an EV/sales of 25.3x.